A Potential Method to Help Predict Genetic Diseases and Arrange Healthcare: Copy Number Variation Analysis

References (7)

1. Ceylan AC. Retrospective evaluation of pathogenic copy number variations detected via chromosomal microarray analysis (International Participated Erciyes Medical Genetics Days 2019). Erciyes Med J 2019; 41(Suppl 1): OP-21–015
2. Crawford K, Bracher-Smith M, Owen D, Kendall KM, Rees E, Pardiñas AF, et al. Medical consequences of pathogenic CNVs in adults: Analysis of the UK Biobank. J Med Genet 2019; 56(3): 131–8
3. Öztürk A, Aykut M, Günay O, Gün İ, Özdemir M, Çıtıl R, et al. Prevalence and factors affecting of hypertension in adults aged 30 years and over in Kayseri province. Erciyes Med J 2011; 33(3): 219–28
4. Şahin H, Aykut M, Öztürk A, Yılmaz M, Gün İ, Çelik N, et al. Obesity prevalence and related factors among medical students in Kayseri. Erciyes Med J 2015; 37(2): 51–8
5. Dundar M, Prakash S, Lal R, Martin DK. Future Biotechnology. The EuroBiotech Journal 2019; 3(2): 53–6
6. Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V, Robson S, et al; Wellcome Trust Case Control Consortium. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 2010; 464(7289): 713–20
7. Gartland KMA, Dundar M, Beccari T, Magni MV, Gartland JS. Advances in biotechnology: Genomics and genome editing. The EuroBiotech Journal 2017; 1(1): 2–9.